OQROGet OQRO Pro
Insider trade

Annovis Bio (ANVS)Director bought ~$6.1K

Michael B Hoffman, Director at Annovis Bio, bought ~$6.1K of Annovis Bio shares.

~$6.1K
Approx. value · 1,489 sh @ $4.13
2.49M
Holds after · shares reported
Traded
Nov 24, 2025
Filed
Nov 25, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 25, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective September 25, 2025, Annovis Bio, Inc. (the “Company”) appointed Mark Guerin, age 57, as Chief Financial Officer of the Company. Prior to joining the Company, Mr. Guerin served as Chief Financial Officer of Onconova Therapeutics, now known as Traws Pharma, Inc. (Nasdaq: TRAW) from 2016 through February, 2025.”
  2. Oct 10, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
  3. Oct 26, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  4. Oct 28, 2025Insider · 2 peopleInsiders: 2 purchases (~$2.2M)
  5. Nov 12, 2025Company filing · Form 8-K · ResultsReported its results
  6. Nov 14, 2025InsiderDirector purchased ~$32K of ANVS shares in the open market
  7. Nov 21, 2025Insider · 1 personInsiders: 2 purchases (~$70K)
  8. Nov 24, 2025 · this disclosureInsiderDirector purchased ~$6.1K of ANVS shares in the open market

What came next

  1. Nov 24, 2025Insider · 1 personInsiders: 7 purchases (~$314K)
  2. Dec 8, 2025Insider · 1 personInsiders: 2 purchases (~$194K)
  3. Mar 16, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Annovis Bio

OQRO holds no insider, Congress, fund or contract record for Annovis Bio dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANVS page.

Other recent filings by Michael B Hoffman, Director

The full history of Michael B Hoffman, Director is on the profile page.

How this filing works

Other disclosures at Annovis Bio

Everything OQRO holds on this company is on its ANVS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data